Clinical features of chronic obstructive pulmonary disease in HIV-infected patients and the association of smoking with clinical, functional, and immunological parameters in this patient category
Science and Innovations in Medicine · 2026-10-21 · 11 (4) · 269-275
DOI: 10.35693/sim706435 ↗Rezumat
Aim: to study the clinical features of chronic obstructive pulmonary disease (COPD) in HIV-infected patients and to evaluate the association of smoking intensity with respiratory function and immunological status. Material and methods. In a cross-sectional study, a total of 33 patients were examined and divided into two age- and sex-comparable groups. The first group included 15 individuals with HIV and COPD comorbidity, and the second (comparison) group included 18 patients with COPD without HIV. Clinical assessment was performed using the mMRC and CAT scales, spirometry, and diffusing capacity of the lungs for carbon monoxide (DLCO). Laboratory tests included CD4 lymphocyte counts, viral load, and inflammatory markers (CRP, fibrinogen). Statistical analysis was performed using the Mann - Whitney and Fisher tests, as well as the Spearman correlation coefficient. Results. Patients with HIV infection had a significantly higher smoking intensity (median 27.2 (22.5; 33.5) vs. 19.4 (15.0; 24.5) pack-years, p = 0.014), a lower body mass index (21.1 (19.5; 22.8) vs. 24.5 (22.1; 26.2) kg/m², p = 0.038), and higher mMRC (p = 0.008), CAT (p = 0.011), and systemic inflammatory marker levels. In the HIV-infected group, smoking intensity showed a significant positive correlation with the frequency of COPD exacerbations (r = 0.76, p = 0.001) and HIV viral load (r = 0.58, p = 0.023), as well as an inverse correlation with CD4+ lymphocyte counts (r = -0.71, p = 0.003). Conclusions. In patients with HIV and COPD comorbidity, more pronounced respiratory symptoms, reduced lung diffusing capacity, and elevated systemic inflammation markers are observed alongside higher smoking intensity. The identified associations between pack-years, COPD exacerbation rate, and immunovirological parameters highlight the clinical importance of smoking cessation programs in the multidisciplinary management of HIV-infected patients with COPD.
EUVIMED